You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

targeted DNA-damaging chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)

Recruiting
  • Metastatic Breast Cancer
  • Taipei City, Please Select, Taiwan
  • +2 more
Nov 27, 2022

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Colorectal Cancer, Liver Metastasis Colon Cancer Trial in Edmonton (stereotactic body radiation treatment (SBRT))

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastasis Colon Cancer
  • stereotactic body radiation treatment (SBRT)
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 7, 2023

Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Recruiting
  • Non Small Cell Lung Cancer
  • anti-PD-1 or anti-PD-L1
  • +2 more
  • Shanghai, China
    Oncology Department, Shanghai Chest Hospital
Jul 26, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

Multi-layer Data to Improve Diagnosis, Predict Therapy

Recruiting
  • High Grade Ovarian Serous Adenocarcinoma
  • WGS and RNA sequencing
  • +2 more
  • Turku, Finland
    Turku University Hospital
Apr 26, 2022

NSCLC Trial in Washington, Hackensack, Neptune (Nivolumab, Ipilimumab, Carboplatin)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Washington, District of Columbia
  • +2 more
Jan 27, 2023

Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United

Recruiting
  • Embryonal Rhabdomyosarcoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Aug 17, 2022

Metastatic Castrate Resistant Prostate Cancer, BRCA1, BRCA2, PALB2 Genetic Mutations Trial in United States (Carboplatin,

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • +2 more
  • West Los Angeles, California
  • +13 more
Nov 23, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 26, 2023

Breast Cancer Trial in United States (Paclitaxel, Cyclophosphamide, Carboplatin)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +5 more
Jan 31, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Biospecimen Collection
  • +4 more
  • Anchorage, Alaska
  • +357 more
Jan 28, 2023

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Circulating Tumor Cells (CTC) in Lung Cancer

Recruiting
  • Lung Neoplasms
  • Blood draw
  • Indianapolis, Indiana
  • +1 more
Sep 23, 2022

Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

Not yet recruiting
  • Resectable Intrahepatic Cholangiocarcinoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
Aug 19, 2022

Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

Recruiting
  • Urothelial Cancer
  • Niraparib plus Cabozantinib
  • Barcelona, Cataluña, Spain
  • +10 more
Feb 8, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma Trial in

Recruiting
  • Advanced Cervical Adenocarcinoma
  • +12 more
  • Biospecimen Collection
  • +11 more
  • Los Angeles, California
  • +15 more
Aug 23, 2022

Hepatocellular Carcinoma Trial in Beijing (1mg NWRD06 administered by electroporation, 4mg NWRD06 administered by

Recruiting
  • Hepatocellular Carcinoma
  • 1mg NWRD06 administered by electroporation
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Oct 15, 2023